Abstract
Clinically, botulinum toxin A blocks the cholinergic innervation of the target tissue. Recently, it has been proved effective not only at a neuromuscular junction but also within parasympathetic or sympathetic neural synapses. Seven women with pain on genitalia that could not be controlled with conventional pain managements were enrolled in this study. Twenty to 40 U of botulinum toxin A were used in each injection. Injection sites were the vestibule, levator ani muscle or the perineal body. Repeat injections were administered every 2 weeks if the patient's symptoms had not fully subsided. In all patients, pain had disappeared with botulinum toxin A injections. Five patients needed to be injected twice; the other two patients needed only one injection. We did not observe complications related to botulinum toxin A injections, such as pain, hemorrhage, infection, muscle paralysis or other complications. The subjective pain score improved from 8.3 to 1.4, and no one has experienced a recurrence (the follow-up period was four to 24 months, with a mean follow-up of 11.6 months). Botulinum toxin A is effective in blocking nociception. Even though further investigation and well-controlled study will be necessary, we suggest that the botulinum toxin therapy would be useful and safe in managing vulvodynia of muscular or neuroinflammatory origins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aoki R . The development of BOTOX – its history and pharmacology. Pain Digest 1998; 8: 337–341.
Arezzo JC . Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002; 18: S125–S132.
Guyer BM . Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999; 3: 427–431.
Gunter J, Brewer A, Tawfik O . Botulinum toxin A for vulvodynia: a case report. J pain 2004; 5: 238–240.
Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB . Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 2004; 64: 871–875.
Davis GD, Hutchison CV . Clinical management of vulvodynia. Clin Obstet Gynecol 1999; 42: 221–233.
Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Torebjork E . Psychophysical evidence of nociceptor sensitiazation in vulvar vestibulitis syndrome. Pain 2001; 94: 177–183.
Edwards L . New concepts in vulvodynia. Am J Obstet Gynecol 2003; 189: S24–S40.
Westrom LV, Willen R . Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 1998; 91: 572–576.
Simpson LL . Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol 1986; 26: 427–453.
Angaut-Ptet D, Molgo J, Comella JX, Faille L, Tabti N . Terminal sprouting in mouse neuromuscular functions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 1990; 7: 799–808.
Naumann M, Jost WH, Toyka KV . Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch Neurol 1999; 56: 914–916.
Jabbari B, Maher N, Difasio MP . Botulinum toxin improved burning pain and allodynia in two patients with spinal cord pathology. Pain Med 2003; 4: 206–210.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, H., Chung, W. & Shim, B. Botulinum toxin A for the management of vulvodynia. Int J Impot Res 19, 84–87 (2007). https://doi.org/10.1038/sj.ijir.3901487
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901487
Keywords
This article is cited by
-
Alternative Clinical Indications of Botulinum Toxin
American Journal of Clinical Dermatology (2020)
-
Wenn das Becken schmerzt
Schmerzmedizin (2019)
-
Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches
Drugs (2019)
-
Methodological approaches to botulinum toxin for the treatment of chronic pelvic pain, vaginismus, and vulvar pain disorders
International Urogynecology Journal (2019)
-
Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis
Archives of Gynecology and Obstetrics (2019)